These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 4132718)
1. Editorial: Drug metabolism in disease. Lancet; 1974 Apr; 1(7861):790-1. PubMed ID: 4132718 [No Abstract] [Full Text] [Related]
2. Interindividual differences in drug oxidation: clinical importance. Sjöqvist F; von Bahr C Drug Metab Dispos; 1973; 1(1):469-82. PubMed ID: 4149420 [No Abstract] [Full Text] [Related]
3. Genetic factors in hepatic drug oxidation. Kalow W; Inaba T Prog Liver Dis; 1976; 5():246-58. PubMed ID: 775542 [No Abstract] [Full Text] [Related]
4. [The importance of the biliary excretion of drugs in the human]. Siegers CP; Klaassen CD Dtsch Med Wochenschr; 1983 Oct; 108(41):1564-70. PubMed ID: 6352227 [No Abstract] [Full Text] [Related]
6. Drug-disease interactions: a review of the literature. Gidumal R; Kupersmith J Mt Sinai J Med; 1981; 48(1):7-20. PubMed ID: 7010124 [No Abstract] [Full Text] [Related]
7. Individual differences in the disposition of drugs metabolised in the body. Alvan G Clin Pharmacokinet; 1978; 3(2):155-75. PubMed ID: 346288 [No Abstract] [Full Text] [Related]
8. The influence of liver diseases on drug disposition. Roberts RK; Branch RA; Desmond PV; Schenker S Clin Gastroenterol; 1979 Jan; 8(1):105-21. PubMed ID: 369741 [No Abstract] [Full Text] [Related]
9. [Does the elimination of medication interest the physician?]. Singlas E Sem Hop; 1981 Oct 18-25; 57(39-40):1648-52. PubMed ID: 6119792 [No Abstract] [Full Text] [Related]
10. Enhanced drug metabolism and renal dysfunction. Németh I; Szeleczki T Br J Clin Pharmacol; 1981 Jan; 11(1):92-3. PubMed ID: 7213515 [No Abstract] [Full Text] [Related]
11. [Inter-individual differences in pharmacokinetics in humans: clinical importance]. Sjöqvist F Minerva Med; 1973 Mar; 64(17):866-79. PubMed ID: 4703858 [No Abstract] [Full Text] [Related]
12. [Dosage of drugs with regard to their distribution volume and biological half-life]. Dahl SG Tidsskr Nor Laegeforen; 1974 Jun; 94(18):1201-2. PubMed ID: 4839999 [No Abstract] [Full Text] [Related]
13. Impairment of drug elimination in patients with liver disease. Narang AP; Datta DV; Mathur VS Int J Clin Pharmacol Ther Toxicol; 1985 Jan; 23(1):28-32. PubMed ID: 3988389 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic consequences of aging. Richey DP; Bender AD Annu Rev Pharmacol Toxicol; 1977; 17():49-65. PubMed ID: 326170 [No Abstract] [Full Text] [Related]
15. Drug therapy. Binding of drugs to serum albumin (second of two parts). Koch-Weser J; Sellers EM N Engl J Med; 1976 Mar; 294(10):526-31. PubMed ID: 765821 [No Abstract] [Full Text] [Related]